What is the LABD 30-day expected price range?

As of Jul 15, 2026, with LABD at $7.92 and ATM IV at 105.1%, the implied 30-day one-standard-deviation range is approximately ±$2.39, or about $5.53 to $10.31.

What does LABD risk-neutral density tell us?

Risk-neutral density is the probability distribution of future LABD price implied by listed option prices. Extracted via Breeden-Litzenberger (twice-differentiating the call price function with respect to strike), it represents the pricing kernel rather than the real-world probability of outcomes. Persistent skew or fat-tail features in the density reflect how the market is pricing tail risk.

How does LABD ATM IV translate to a probability range?

ATM IV is annualized; multiplying by sqrt(t/365) scales it to the chosen tenor. Under lognormal assumptions, the resulting standard deviation defines the ±1σ band that contains roughly 68% of outcomes, ±2σ for 95%. Empirical equity returns have fatter tails than log-normal, so the implied tail probabilities under-state realized tail frequency in stressed regimes.

Direxion Daily S&P Biotech Bear 3X ETF (LABD) Probability Analysis

Probability analysis extracts the risk-neutral probability distribution implied by option prices. It shows the market-implied likelihood of the underlying reaching various price levels by expiration.

Direxion Daily S&P Biotech Bear 3X ETF (LABD) operates in the Financial Services sector, specifically the Asset Management - Leveraged industry, with a market capitalization near $18.1M, listed on AMEX, carrying a beta of -3.18 to the broader market. The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. public since 2015-05-28.

Snapshot as of Jul 15, 2026.

Spot Price: $7.92
ATM IV: 105.1%
IV Rank: 53.8%
IV Percentile: 91.3%
HV 20-Day: 117.5%
IV Skew 25Δ: -0.086

As of Jul 15, 2026, Direxion Daily S&P Biotech Bear 3X ETF (LABD) at $7.92 has an ATM IV of 105.1%, implying a 30-day one-standard-deviation range of approximately ±$2.39. IV rank is 53.8% (near its 1-year median). IV percentile is 91.3%. The 25-delta skew is -0.086: downside tail priced richer than upside, biasing probability mass below spot. Under lognormal assumptions roughly 68% of outcomes fall within ±1σ and 95% within ±2σ; risk-neutral probability analysis refines this by extracting the market-implied distribution directly from options prices, capturing the fat tails that real markets exhibit.

How LABD probability analysis Data Feeds Strategy Selection

Strategy selection on Direxion Daily S&P Biotech Bear 3X ETF options does not derive from any single metric in isolation. The probability analysis view above sits inside a broader read: ATM IV currently sits at 105.1% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the probability analysis data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

How to read the LABD probability distribution

The probability cone above is the option-market-implied distribution of where Direxion Daily S&P Biotech Bear 3X ETF spot could end up at expiration. It's derived from the implied-volatility surface via a risk-neutral pricing transformation, not from historical realized returns. With ATM IV at 105.1% and spot at $7.92, the 1σ band is approximately ±36.3% over a 30-day horizon. Recent realized HV-20 of 117.5% runs 12.4 vol points above current implied, an inverted regime where premium buyers are underpaying.

LABD risk-neutral vs real-world probabilities

The probabilities derived from option prices reflect the market's risk-adjusted view, not the realized statistical distribution. Risk-neutral probabilities include the equity risk premium and skew preferences priced into options, so they tend to overstate tail probability and understate upside drift relative to actually-realized outcomes. LABD's put-skewed 25-delta surface (-0.086) means downside risk-neutral probabilities are higher than upside - the empirical bias is well-documented. For probability-of-touch calculations and assignment-risk modeling, risk-neutral is the right benchmark. For position-sizing your own conviction, blend with realized-volatility-based statistics from the HV columns.

Trading the LABD distribution

Probability-driven strategies aim to capture mispricings between the implied distribution and your own probability assessment. Premium-selling structures (credit spreads, iron condors, cash-secured puts) profit when the implied distribution overprices tail probability relative to realized; premium-buying (debit spreads, long calls/puts, long straddles) profits in the reverse. Always pair probability-driven strategy selection with a stop loss or wing-defined risk - the implied distribution is a snapshot, and regime shifts can invalidate it intraday.

Learn how risk-neutral density is reported and how to read the data →

Chart aggregates top-ranked contracts by strike from the institutional-grade nightly options scan. Sparse coverage on long-tail tickers reflects the scan's S&P 500/400/600 + ETF focus.

LABD highest implied-volatility contracts

Type	Strike	Expiration	Volume	OI	IV	Bid	Ask
CALL	$7.00	Jul 17, 2026	5	183	916.4%	$0.80	$1.50
CALL	$8.00	Jul 17, 2026	39	812	499.4%	$0.15	$0.25

Top 2 contracts from the institutional-grade nightly options scan; ranked by iv within the broader S&P 500/400/600 + ETF universe.

Frequently asked LABD probability analysis questions

What is the LABD 30-day expected price range?: As of Jul 15, 2026, with LABD at $7.92 and ATM IV at 105.1%, the implied 30-day one-standard-deviation range is approximately ±$2.39, or about $5.53 to $10.31.
What does LABD risk-neutral density tell us?: Risk-neutral density is the probability distribution of future LABD price implied by listed option prices. Extracted via Breeden-Litzenberger (twice-differentiating the call price function with respect to strike), it represents the pricing kernel rather than the real-world probability of outcomes. Persistent skew or fat-tail features in the density reflect how the market is pricing tail risk.
How does LABD ATM IV translate to a probability range?: ATM IV is annualized; multiplying by sqrt(t/365) scales it to the chosen tenor. Under lognormal assumptions, the resulting standard deviation defines the ±1σ band that contains roughly 68% of outcomes, ±2σ for 95%. Empirical equity returns have fatter tails than log-normal, so the implied tail probabilities under-state realized tail frequency in stressed regimes.